PT1300160E - Processo para estabilizar uma preparação - Google Patents

Processo para estabilizar uma preparação Download PDF

Info

Publication number
PT1300160E
PT1300160E PT1932213T PT01932213T PT1300160E PT 1300160 E PT1300160 E PT 1300160E PT 1932213 T PT1932213 T PT 1932213T PT 01932213 T PT01932213 T PT 01932213T PT 1300160 E PT1300160 E PT 1300160E
Authority
PT
Portugal
Prior art keywords
stabilizing preparation
stabilizing
preparation
Prior art date
Application number
PT1932213T
Other languages
English (en)
Inventor
Tadashi Mukai
Yuso Tomohira
Minoru Kashimoto
Masakazu Nagasawa
Tetsuroh Ichiba
Daisuke Kuribayashi
Yoshikazu Oka
Hajime Toguchi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT1300160E publication Critical patent/PT1300160E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT1932213T 2000-05-24 2001-05-23 Processo para estabilizar uma preparação PT1300160E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000152969 2000-05-24

Publications (1)

Publication Number Publication Date
PT1300160E true PT1300160E (pt) 2014-05-02

Family

ID=18658308

Family Applications (1)

Application Number Title Priority Date Filing Date
PT1932213T PT1300160E (pt) 2000-05-24 2001-05-23 Processo para estabilizar uma preparação

Country Status (13)

Country Link
US (1) US7867514B2 (pt)
EP (1) EP1300160B1 (pt)
JP (1) JP4902928B2 (pt)
KR (1) KR100741937B1 (pt)
CN (1) CN100377746C (pt)
AU (1) AU5881001A (pt)
CA (1) CA2408796C (pt)
CY (1) CY1115023T1 (pt)
DK (1) DK1300160T3 (pt)
ES (1) ES2461196T3 (pt)
HK (1) HK1055675A1 (pt)
PT (1) PT1300160E (pt)
WO (1) WO2001089573A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043704A1 (en) 2000-12-01 2002-06-06 Kyowa Hakko Kogyo Co., Ltd. Composition improved in solubility or oral absorbability
KR101220643B1 (ko) * 2006-08-16 2013-01-14 알리코제약(주) 사포그릴레이트 함유 경구투여 형태의 약제
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
EP3409294A1 (en) 2017-06-01 2018-12-05 Przedsiebiorstwo Farmaceutyczne Lek-Am Sp Z O. O. Tablets containing cilostazol of specific particle size distribution
JP7233852B2 (ja) * 2018-04-17 2023-03-07 キョーリンリメディオ株式会社 変色が抑制された固形製剤
AR121187A1 (es) * 2019-12-27 2022-04-27 Chugai Pharmaceutical Co Ltd Método para clasificar, evaluar o fabricar lauril sulfato de sodio de materia prima o formulación farmacéutica que lo contiene
US11718753B2 (en) 2020-05-28 2023-08-08 Ethicon, Inc. Topical skin closure compositions and systems
CN115212206B (zh) * 2022-08-15 2023-04-18 江苏知原药业股份有限公司 一种含吡非尼酮的药物组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168478A (en) * 1960-07-28 1965-02-02 Gen Aniline & Film Corp Highly alkaline surface active compositions
JPS6019715A (ja) * 1983-07-12 1985-01-31 Nisshin Flour Milling Co Ltd 安定なイソカルボスチリル製剤
US5292520A (en) * 1990-09-13 1994-03-08 Akzo N.V. Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
WO1994002140A1 (en) * 1992-07-17 1994-02-03 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
EG20321A (en) * 1993-07-21 1998-10-31 Otsuka Pharma Co Ltd Medical material and process for producing the same
JP3486930B2 (ja) 1993-09-10 2004-01-13 ライオン株式会社 口腔用組成物
IL115241A (en) 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
TW412425B (en) 1994-10-18 2000-11-21 Kao Corp Dentifrice composition having capsule particles
US5817337A (en) 1995-10-06 1998-10-06 Desenna; Richard A. Disinfectant effervescent tablet formulation
MXPA98003802A (es) 1995-11-14 2005-04-29 Abbott Gmbh & Co Kg Preparaciones de hormona tiroidea estabilizadas ymetodos para fabricar las mismas.
WO1998000136A1 (en) 1996-07-01 1998-01-08 Pfizer Inc. Virginiamycin mixture
JPH10130142A (ja) * 1996-10-31 1998-05-19 Zensei Yakuhin Kogyo Kk 放出持続型圧縮製剤
JP3618205B2 (ja) 1997-10-09 2005-02-09 サンスター株式会社 泡沫状フッ素塗布剤
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
JP4221068B2 (ja) 1997-12-17 2009-02-12 興和創薬株式会社 テオフィリン徐放性錠剤及びその製造方法
JPH11189546A (ja) 1997-12-25 1999-07-13 Saitama Daiichi Seiyaku Kk 経皮吸収促進剤
JPH11189531A (ja) 1997-12-26 1999-07-13 Dai Ichi Seiyaku Co Ltd 経粘膜投与用医薬組成物
GB9804648D0 (en) * 1998-03-06 1998-04-29 Zeneca Ltd Chemical compounds
US6187790B1 (en) * 1999-03-04 2001-02-13 Neal R. Cutler Use of cilostazol for treatment of sexual dysfunction
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
KR20010052557A (ko) * 1998-06-05 2001-06-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 산화마그네슘을 사용한, ａｃｅ 억제제 함유 조성물의안정화
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US6451813B1 (en) * 2001-01-26 2002-09-17 R. T. Alamo Ventures I, Llc Treatment of gastroparesis in certain patient groups

Also Published As

Publication number Publication date
AU5881001A (en) 2001-12-03
EP1300160A1 (en) 2003-04-09
EP1300160B1 (en) 2014-03-12
WO2001089573A1 (fr) 2001-11-29
CN100377746C (zh) 2008-04-02
US7867514B2 (en) 2011-01-11
JP4902928B2 (ja) 2012-03-21
CA2408796A1 (en) 2002-11-15
CY1115023T1 (el) 2016-12-14
CA2408796C (en) 2009-12-15
US20030161873A1 (en) 2003-08-28
KR100741937B1 (ko) 2007-07-24
CN1430520A (zh) 2003-07-16
KR20030009498A (ko) 2003-01-29
ES2461196T3 (es) 2014-05-19
DK1300160T3 (da) 2014-03-24
EP1300160A4 (en) 2009-07-29
HK1055675A1 (en) 2004-01-21

Similar Documents

Publication Publication Date Title
HK1052183A1 (zh) 製造tetrahydrobenzothiepines的方法
IL200255A (en) Method of preparing o-desmethyl-venlafaxine
IL151059A0 (en) Method for the preparation of citalopram
HRP20030064A2 (en) Method for the preparation of citalopram
HUP0300078A3 (en) Method for the preparation of citalopram
PL350308A1 (en) Method of obtaining organosilanes
AU8415901A (en) Method of stabilizing particulates
GB2366639B (en) Method of comparing parts
IL151467A0 (en) Method for the preparation of citalopram
AU5823901A (en) Method for the preparation of citalopram
IL151490A0 (en) Method for the preparation of citalopram
AU5881001A (en) Method of stabilizing preparation
IL148525A0 (en) Method for the preparation of citalopram
PL346034A1 (en) Method of obtaining substituted banzoylcyanide aminohydrazones
IL151489A0 (en) Method for the preparation of citalopram
GB0008921D0 (en) Method of treatment
AU2001258810B2 (en) Method of stabilizing preparation
AU8626801A (en) Method of forming complex
AU2001258810A1 (en) Method of stabilizing preparation
PL344809A1 (en) Method of obtaining n-tert-butoxycarbonyl-l-ornitin
PL344651A1 (en) Method of obtaining 4-demethoxydaunomycinone
PL344228A1 (en) Method of obtaining paclitaxtel
PL339713A1 (en) Method of obtaining triallylmethylamines
GB0021476D0 (en) Method of attachment
GB0031757D0 (en) Method of manufacture